Oncology Medical News about SCT

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cytotoxic crossmatch analysis before allo-SCT is a poor diagnostic tool for prediction of rejection
Bone Marrow Transplantation, 07/01/09

Mattsson J et al. - Positive T- and/or B-crossmatch before SCT had no predictive value for survival in this study as compared with patients with a negative crossmatch. The pretransplant cytotoxic T- and/or B-crossmatch is a poor predictor of rejection after allo-SCT.

<< Previous
Infections in non-myeloablative hematopoietic stem cell...

Next >>
Mutations in the mitochondrial genome confer resistance of cancer...

Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial
Haematologica, 10/07/09 Relevance Score: 88%

Parental stress and perceived vulnerability at 5 and 10 years after pediatric SCT
Bone Marrow Transplantation, 11/05/09 Relevance Score: 87%

Management of relapse after allo-SCT for AML and the role of second transplantation
Bone Marrow Transplantation, 10/29/09 Relevance Score: 87%

Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT
Bone Marrow Transplantation, 10/07/09 Relevance Score: 87%